Elimination Half-Life of Immediate-Release Adderall 5mg
The elimination half-life of immediate-release Adderall (mixed amphetamine salts) is approximately 9-11 hours for d-amphetamine and 11.5-13.8 hours for l-amphetamine in adults, with children exhibiting shorter half-lives of approximately 7 hours. 1
Pharmacokinetic Details
The FDA drug label for Adderall provides the most authoritative data on this medication's elimination characteristics 1:
- d-amphetamine half-life: 9.77 to 11 hours
- l-amphetamine half-life: 11.5 to 13.8 hours
- Peak plasma concentration (Tmax): Approximately 3 hours post-dose for both isomers
- Dose proportionality: Linear pharmacokinetics from 10-30 mg doses
Age-Related Differences
Children metabolize amphetamines more rapidly than adults, with replicated studies demonstrating a plasma half-life of approximately 7 hours in pediatric populations compared to 10-12 hours in adults 2. This age-dependent difference is clinically significant when dosing schedules are determined.
Clinical Implications
The half-life information is relevant for understanding:
- Duration of therapeutic effect: Immediate-release formulations typically provide 3-4 hours of behavioral effects, which appear during the absorption phase and do not correlate directly with plasma half-life 3
- Dosing frequency: Multiple daily doses are necessary due to the short duration of action despite the longer elimination half-life
- Drug accumulation: With twice or thrice daily dosing, steady-state is typically achieved within 2-3 days
Important Caveat: Half-Life vs. Duration of Action
The therapeutic effects of amphetamines disappear well before the medication is eliminated from plasma, a phenomenon called "clockwise hysteresis" 3. Behavioral effects last only 3-4 hours despite the 9-13 hour elimination half-life, meaning the half-life primarily predicts drug accumulation patterns rather than duration of symptom control.
Factors Affecting Elimination
The elimination half-life can be significantly altered by:
- Urinary pH: Alkaline urine (pH >7) decreases renal elimination and prolongs half-life; acidic urine increases elimination 1
- Renal function: Approximately 30-40% of amphetamine is excreted unchanged in urine; renal impairment prolongs exposure 1
- Hepatic function: Hepatic metabolism accounts for the remaining fraction; liver dysfunction can prolong elimination 1
The dose of 5mg does not alter the half-life, as amphetamine exhibits dose-proportional pharmacokinetics with consistent elimination parameters across the therapeutic dose range 1.